FK Group joins M+W Group team delivering state-of-the-art new cancer centre

External envelope specialist, the FK Group, has been appointed to the construction of the new Manchester Cancer Research Centre (MCRC) being delivered by M+W Group, which is being funded by The University of Manchester, Cancer Research UK and The Christie NHS Foundation Trust.

Working alongside main contractor, M+W Group and key project partner, Pochin Construction, FK Group will install 2,500m2 of rain screen cladding, 1000m2 of the high-tech Bauder flat roof system and 500m2 of zinc roofing.

The multi-million pound contract is for the construction of the MCRC building envelope including roofing and cladding at the new offices and laboratory at the facility. The works have been purposefully designed to support the building’s energy efficiency and extend its life expectancy.

When the new facility is finished in the summer 2014, it will house 250 staff including 150 University scientists whose research will focus on understanding how cancer starts, develops and progresses. Working alongside these researchers, The Christie will relocate 100 clinical trials support staff to the second floor of the building.

Francis Keenan, managing director of the FK Group, said: “This is a fantastic, high-profile project to be appointed to and we are proud to be involved with the creation of one of the world’s leading cancer research centres.

"It’s a challenging project due to its specialised nature and scale. However, we have undergone a 20-week design and lead in period and I am confident that our highly skilled site team will deliver on time and to the budget.”

The project architect is Wilson Mason LLP.

ENDS

Notes for editors

For further information, please contact Fiona Kirwan Tel: 0161 233 1814 / fiona@truth-pr.co.uk

FK Group

Established in 1979, FK is a nationwide roofing and cladding specialist offering a range of services from building envelopes to maintenance.

About the new MCRC Research Building:

The new building is vital to support ongoing expansion of research activities with tremendous potential for future breakthroughs that improve treatment for cancer patients. It will provide space for around 250 staff and complements existing facilities on the site, promoting collaboration between doctors and scientists to take cancer research from the laboratory to the clinic. The building is expected to be operational in summer 2014.

About the Manchester Cancer Research Centre:
 

The MCRC was created in 2006 as a partnership between three key organisations:

·         The University of Manchester – one of Britain’s biggest universities with an international reputation for its research and four Nobel Laureates on its current staff. In the 2008 UK Research Assessment Exercise, Manchester was ranked third in the UK for its research power (combining research quality with critical mass) and top in the UK for quality in cancer studies.

·         Cancer Research UK – the world’s leading independent organisation dedicated to cancer research. It provides core funding for the Paterson Institute for Cancer Research, which became part of the University in 2006 and is at the heart of the work of the MCRC.

·         The Christie – an internationally-recognised specialist cancer centre and leader in clinical research. The Christie treats more than 40,000 patients a year, with around 26% patients referred from other parts of the country for specialist treatment. It has been achieving research world firsts for over 100 years and runs the largest, single-site, early-phase trials unit in the world.